We also have a late stage program Urocortin-2 that we hope to be reporting out Phase IIb data in Acute Congestive Heart Failure in the coming weeks. Conference comming up next week. Will we get data?
Buncha catalysts coming up in the next few months. Looks like some nice consolidation going on.